Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient
about
sameAs
New insights of an old defense system: structure, function, and clinical relevance of the complement system.Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis.Henoch-Schönlein purpura complicated with severe gastrointestinal bleeding.
P2860
Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Combined treatment with nafamo ...... enia in a hemodialysis patient
@ast
Combined treatment with nafamo ...... enia in a hemodialysis patient
@en
Combined treatment with nafamo ...... enia in a hemodialysis patient
@nl
type
label
Combined treatment with nafamo ...... enia in a hemodialysis patient
@ast
Combined treatment with nafamo ...... enia in a hemodialysis patient
@en
Combined treatment with nafamo ...... enia in a hemodialysis patient
@nl
prefLabel
Combined treatment with nafamo ...... enia in a hemodialysis patient
@ast
Combined treatment with nafamo ...... enia in a hemodialysis patient
@en
Combined treatment with nafamo ...... enia in a hemodialysis patient
@nl
P2093
P921
P1433
P1476
Combined treatment with nafamo ...... enia in a hemodialysis patient
@en
P2093
E Nakazawa
H Takahashi
S Yanagiba
Y Masunaga
P304
P407
P577
2003-06-01T00:00:00Z